Fundz

Ivexsol® Closes $23.8M Series A-3 Financing; Funds To Revolutionize The Production Of Lentiviral Vectors

PRIVATEJan 26, 2023

Amount Raised

$23.8 Million

Round Type

Series A

LexingtonManufacturingBiotechnology

Description

iVexSol Inc., a technology-based lentiviral vector (LVV) contract development and manufacturing organization (CDMO), announced $23.8 million in Series A-3 funding. New investors Bristol Myers Squibb (NYSE: BMY), Charles River Laboratories (NYSE: CRL) and Asahi Kasei Medical, a division of Asahi Kasei (NYSE: AHKSY), join existing investors which include Casdin Capital and BioLife Solutions (Nasdaq: BLFS) to close Series A financing at a total of more than $39 million.

Quick answer

iVexSol raised $23.8 Million in a Series A round, dated January 26, 2023. iVexSol is based in Lexington, South Carolina, United States.

How much did iVexSol raise?
iVexSol raised $23.8 Million in a Series A round on January 26, 2023.
What does iVexSol do?
iVexSol, Inc. is a viral vector manufacturing company founded on a proprietary, next-generation, stable lentiviral vector production process that transforms the way these essential gene-delivery vehicles are made.
Where is iVexSol based and how big is it?
iVexSol is based in Lexington, South Carolina, United States.

Source: Fundz verified event record.

Who else raised in Manufacturing and Biotechnology around the same time

Companies in the same sectors as iVexSol that raised within 45 days of this round, from Fundz verified event records.

  • Virax Biolabs raised $4M on March 10, 2023.
  • NuVision Biotherapies raised $1.3M (Seed) on March 9, 2023.
  • ViridiCO2 raised $3.9M (Seed) on March 7, 2023.
  • 22nd Century raised $21M (Debt Financing) on March 3, 2023.
  • PMGC Holdings Inc. raised $750K (Seed) on March 3, 2023.
  • Wilson Wolf Manufacturing raised an undisclosed amount on March 1, 2023.

Who to call at iVexSol, and when

A new round usually means iVexSol is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day iVexSol raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at iVexSol, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at iVexSol. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

iVexSol

Location

Lexington, South Carolina, United States

About

iVexSol, Inc. is a viral vector manufacturing company founded on a proprietary, next-generation, stable lentiviral vector production process that transforms the way these essential gene-delivery vehicles are made. Its technology will greatly reduce the complexity, cost, and development time of these critical reagents, thereby accelerating the development and enabling greater access to life-changing cell and gene therapies. For more information visit www.ivexsol.com.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment iVexSol raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for iVexSol's next move

See what Strategic adds

Funding Insights

What this usually means
Typical timeline to Series B
Series A companies typically raise their next round in 10-18 months

iVexSol raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.